Heart failure is one of the most common complications of diabetes. Cardiologists at the ADA conference in San Diego discussed current gaps and their proposed solutions when treating diabetes and heart failure.

Dr. Mikhail Kosiborod, cardiologist at Saint Luke’s Mid America Heart Institute and Vice President of Research at Saint Luke's Health System, presented the concept of a cardiometabolic center of excellence, aiming to provide coordinated, team-based care for patients with cardiometabolic diseases. This approach focuses on optimizing patient outcomes and improving adherence to guidelines. 

Dr. Kosiborod shared data from the center's initial implementation, showing significant improvements in patient care, including reductions in insulin use and better achievement of treatment targets in weight and lipids.

Read the full diaTribe Learn article: The Future of Cardiometabolic Care

Related Content

Nov. 21, 2022

Pharmacy Times: Dapagliflozin Improves Symptom Burden, Health-Related Quality of Life in Patients with Heart Failure

The Pharmacy Times shares findings from the DELIVER phase 3 trial presented at the American Heart Association (AHA) Scientific Sessions 2022.
Medscape logo
Oct. 3, 2022

Medscape: Improve Diagnosis of Type of Heart Failure Common in Diabetes

Medscape talked to Dr. Mikhail Kosiborod about how clinicians can be more diligent in evaluating people at high risk for developing heart failure with reduced ejection fraction.
May. 26, 2022

TCTMD: Beyond the Data: DEFINE-HF and PRESERVED-HF

TCTMD talked to Dr. Mikhail Kosiborod about the DEFINE-HF and PRESERVED-HF trials presented at the European Society of Cardiology Heart Failure Congress.